Medplus Health Services Limited announced that its promoters, Agilemed Investments Private Limited and Mr. Gangadi Madhukar Reddy (Managing Director & CEO), have executed a Debenture Trust Deed with Catalyst Trusteeship Limited on December 12, 2025. This action is related to the refinancing of Agilemed Investments Private Limited's existing debt through the issuance of Non-Convertible Debentures (NCDs) amounting up to ₹175 crore. The interest rate for these NCDs is set at 12.72% per annum, compounded monthly, with an additional initial coupon of 1% on the principal amount. During the interim period of this refinancing, the aggregate pledge of shares by the promoter group is expected to temporarily increase from the current 23.91% to 27.96%. Upon successful completion of the debt refinancing and release of existing pledged shares, the promoter group's share pledge is anticipated to reduce to 24.48%. The company has provided disclosures as required by SEBI LODR regulations, confirming that Medplus Health Services Limited is not a direct party to the agreement. The promoters collectively hold 40.29% of the company's equity shares. The announcement also states that the details of this agreement will be available on the company's website and the websites of BSE and NSE.
